Patients
Sustainability Report > Patients > Access to Healthcare
Sustainability Report

Access to Healthcare

G4-DMA
Management approach

G4-EC8
Significant indirect economic impacts, including the extent of impacts

G4-SO6
Political contributions

G4-DMA
G4-EC8
G4-SO6

Edwards Lifesciences’ work to improve Access to Healthcare supports our Aspirations to Transform Patient Care Through Innovative Technologies and Strengthen Our Communities.

DEFINITION
Supporting the provision of quality care to underserved and diverse patients in global communities, helping to remove regulatory, geographic and economic barriers to treatment, participating in public policy development and providing financial contributions in support of Edwards’ goals and aspirations.

MANAGEMENT APPROACH
ANNUAL PERFORMANCE

Management Approach

Edwards Lifesciences believes patients should have access to affordable and high-quality care. Unfortunately, patients in today’s global healthcare system often face numerous barriers to treatment. These can include access to coverage, geographic barriers, inaccurate physician referrals and policy restrictions. Edwards’ focus on improving access to care contributes to a more sustainable healthcare system and the long-term well-being of our company.

Political Activities

As a highly-regulated medical technology company, public policy impacts our ability to help patients. We are active in the policy making and political process through regular and constructive engagement with government officials, policy makers and stakeholder groups. The goal of Edwards Lifesciences’ policy and political process engagement is to advance sound public policy on areas related to the company’s focus on patient-focused medical innovations for structural heart disease, critical care and surgical monitoring; and to improve patient outcomes and enhance lives.

One way Edwards participates in the policy making process is through political involvement. We outline our approach in our Policy on Political Activities and disclose all federal and state political contributions on our corporate website.

Philanthropic Support

Edwards is proud to serve patients from diverse economic, cultural and racial backgrounds. Through the Edwards Lifesciences Foundation, we support many philanthropic initiatives that increase access for patients in need. The Foundation works to expand access to therapies in all geographies, including those in in emerging markets through support of clinical education and medical mission work. This includes underserved regions all around the world, such as Africa, Brazil, China, Haiti, India, Jamaica, Peru, Puerto Rico, Russia, the Dominican Republic and Vietnam.

Every Heartbeat Matters

Our signature philanthropic initiative is Every Heartbeat Matters (EHM). Our initiative’s goal is to impact the global burden of heart valve disease by supporting the education, screening and treatment of one million underserved people by 2020. To date, our EHM partners have impacted more than 400,000 underserved patients through this initiative. A complete list of grantees is available on our website.


Every Heartbeat Matters

Educational Initiatives for Better Care

Education has the power to form a bridge between between underserved patients and better healthcare. That’s why Edwards offers NewHeartValve.com, a patient-focused website with information and resources about aortic stenosis, treatment options and transcatheter aortic valve replacement (TAVR) centers.

Annual Performance

Edwards is passionate about increasing access for all patients in need. Each year, we challenge ourselves to do more—for our patients, philanthropic partners and communities.

Improving Access to Care

We continued to make progress in 2016 toward our Every Heartbeat Matters (EHM) philanthropic goal of supporting the education, screening and treatment of one million underserved people and we are on track to accomplish our goal by 2020. At the end of 2016, we had invested more than $15 million in this initiative and are energized that our EHM partners had impacted more than 400,000 underserved people. We educated and trained more than 13,000 healthcare professionals around the world who treat underserved populations.

Through the Edwards Lifesciences Foundation, $60,000 in new grants were awarded to non-profit organizations in Cartago, Costa Rica, as we developed our new plant and established community relationships in this region.

In addition to cash donations, we also support in-kind donations to programs focused on increasing access to healthcare for underserved patient populations. Through the AmeriCares’ Medical
Outreach Program, Edwards donated our medical technologies including heart valves, critical care monitoring devices and cardiac surgery products. These technologies help non-profit organizations and charitable medical missions provide cardiac services in some of the most impoverished parts of the world. By the end of 2016, Edwards donated medical products worth more than $500,000 to indigent care.

Educational Initiatives for Better Care

In 2016, NewHeartValve.com had 750,000 visits, bringing the total number of visitors to this website to more than two million. Once on the site, patients and healthcare professionals can find interactive ways to locate TAVR centers and download resources.

Political & Lobbying Expenditures

In 2016, Edwards made $76,000 in state political contributions, and the Edwards PAC made $150,000 in federal contributions. A full list of recipients and donation amounts is available on our website. Additionally, in 2016 a portion of our industry association membership dues were spent on federal lobbying. These include:

  • Advanced Medical Technology Association: $49,777
  • California Life Sciences Association: $12,120

Edwards was named one of seven companies tied for first place in the 2016 CPA-Zicklin Index (among 35, top-five ranked S&P 500 companies) for political disclosure and accountability. This ranking designates Edwards as a “CPA-Zicklin Trendsetter.” The CPA-Zicklin Index benchmarks the political disclosure and accountability policies and practices of leading U.S. public companies. The Index is produced annually by the Center for Political Accountability in conjunction with the Zicklin Center for Business Ethics Research at The Wharton School at the University of Pennsylvania.

Our Aspirations

Transform Patient Care Through Innovative Technologies

Strengthen Our Communities


Material Topics

Sustainability Targets
Impact the global burden of heart valve disease by supporting the education, screening and treatment of 1 million underserved people by 2020.
Strengthen Our Communities
Highlight Story
Edwards in Top-Five Rankings for Political Disclosure and Accountability
Edwards was named one of seven companies tied for first place in the 2016 CPA-Zicklin Index (among 35, top-five ranked S&P 500 companies) for political disclosure and accountability. This ranking designates Edwards as a “CPA-Zicklin Trendsetter.” The CPA-Zicklin Index benchmarks the political disclosure and accountability policies and practices of leading U.S. public companies. The Index is produced annually by the Center for Political Accountability in conjunction with the Zicklin Center for Business Ethics Research at The Wharton School at the University of Pennsylvania.
 
DEFINITION